Patent: 9,181,632
✉ Email this page to a colleague
Summary for Patent: 9,181,632
Title: | C.difficile toxin B CROP domain peptides, antibodies and complexes thereof |
Abstract: | The present invention provides polypeptide domains of C. difficile toxin B (B1, B2, B3, B4) and complexes between the polypeptides and antibodies that bind specifically for the polypeptide. Methods of using the polypeptides to generate antibodies are also provided. |
Inventor(s): | Murgolo; Nicholas (Millington, NJ), Hernandez; Lorraine (Warren, NJ), Sheth; Payal (Somerset, NJ), Strickland; Corey (Martinsville, NJ), Orth; Peter (Bronxville, NY), Therien; Alex (Fanwood, NJ), Reichert; Paul (Montville, NJ), Xiao; Li (Cranbury, NJ) |
Assignee: | MERCK SHARP & DOHME CORP. (Rahway, NJ) |
Application Number: | 14/479,735 |
Patent Claims: | see list of patent claims |
Details for Patent 9,181,632
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZINPLAVA | bezlotoxumab | Injection | 761046 | 10/21/2016 | ⤷ Try a Trial | 2033-09-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |